scispace - formally typeset
D

Dominique Bron

Researcher at Université libre de Bruxelles

Publications -  372
Citations -  15450

Dominique Bron is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Mesenchymal stem cell & Stromal cell. The author has an hindex of 56, co-authored 357 publications receiving 13785 citations. Previous affiliations of Dominique Bron include Free University of Brussels & Institut Jules Bordet.

Papers
More filters
Journal ArticleDOI

Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

TL;DR: Treatment with high-dose chemotherapy and autologous bone marrow transplantation increases event-free and overall survival in patients with chemotherapy-sensitive non-Hodgkin's lymphoma in relapse.
Journal ArticleDOI

Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity.

TL;DR: The selection of CD133‐positive cells enabled us to obtain a homogeneous population of MSCs from UCB and MPB, and these sources may have a major clinical importance thanks to their easy accessibility.
Journal ArticleDOI

Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells

TL;DR: Contact between B-CLL cells and bone marrow stromal cells seems to play a major role in the accumulation and survival of B- CLL cells in the bone marrow, and direct contact between leukemic cells and stronal cells was found to be essential for inhibition of leukeMIC cell apoptosis.
Journal ArticleDOI

Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.

TL;DR: It is reported here that IL-4 protects the B-CLL cells from death by apoptosis (programmed cell death [PCD]), and it is proposed thatIL-4 has an essential role in the pathogenesis of CLL disease, by preventing both the death and the proliferation of the malignant B cells.